Kidney shield? antioxidant supplement tested in chemo patients
NCT ID NCT07564479
First seen May 09, 2026 · Last updated May 17, 2026 · Updated 2 times
Summary
This study tests whether alpha-lipoic acid, a natural antioxidant, can protect the kidneys of cancer patients receiving cisplatin chemotherapy. About 50 adults with solid tumors will take either alpha-lipoic acid or a placebo alongside their chemo. The goal is to see if the supplement reduces kidney damage and improves quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEPHROTOXICITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Minia University Hospital
RECRUITINGMinya, Minya Governorate, 61111, Egypt
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.